1. Defucosylated Mouse-Dog Chimeric Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H77Bf) Exerts Antitumor Activities in Mouse Xenograft Models of Canine Osteosarcoma
   Ren Nanamiya et al, 2023, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
2. Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer
   Mohammad Fereydouni et al, 2022, Frontiers in Oncology CrossRef
3. Overexpression of HER‐2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma ‐ A marker of malignancy and possible therapeutic target
   F. Millanta et al, 2018, Veterinary and Comparative Oncology CrossRef
4. Cancer Immunotherapy
   Philip J. Bergman, 2024, Veterinary Clinics of North America: Small Animal Practice CrossRef
5. Cancer Immunotherapies
   Philip J. Bergman, 2019, Veterinary Clinics of North America: Small Animal Practice CrossRef
6. ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)
   Dane A. Hayes et al, 2017, PLOS ONE CrossRef
7. AllergoOncology – the impact of allergy in oncology: EAACI position paper
   E. Jensen‐Jarolim et al, 2017, Allergy CrossRef
8. Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer
   Xóchitl Zambrano-Estrada et al, 2018, BMC Veterinary Research CrossRef
9. Canine mammary carcinoma: current therapeutic targets and future perspectives – a review
   Muhammad Luqman Nordin et al, 2023, Annals of Animal Science CrossRef
10. Canine non-B, non-T NK lymphocytes have a potential antibody-dependent cellular cytotoxicity function against antibody-coated tumor cells
    Yoseop Kim et al, 2019, BMC Veterinary Research CrossRef
11. Translational oncotargets for immunotherapy: From pet dogs to humans
    Lisa A. Mestrinho et al, 2021, Advanced Drug Delivery Reviews CrossRef